The Impact of a Helplessness and Recovery of an Empowerment Intervention on People Diagnosed With Schizophrenia: Findings From a Randomized Controlled Trial
17. november 2016 opdateret af: Abd Alhadi Hasan, Fakeeh College for Medical Sciences
The Effectiveness of Hopelessness and Helplessness on Recovery Rate Among People Diagnosed With Schizophrenia
A randomized controlled trial was conducted from November 2015 and May 2016 with 112 participants of people diagnosed with schizophrenia.
Participants aged 18 years or older with Diagnostic Statistical Manual (DSM-V) schizophrenia or schizoaffective disorder from outpatient mental health clinics in Jordan, were randomly assigned participants either to receive 6 weeks of a booklet form of intervention with face to face discussion, and treatment as usual (TAU) (intervention, n = 56), or TAU (control, n = 56).
Participants were assessed at baseline, immediately post-intervention (post-treatment1) and at three months follow-up.
The primary outcome measure was change in helplessness score .
Secondary outcomes for PDwS were psychiatric symptoms, recovery rate and quality of life.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
A randomized controlled trial was conducted from November 2015 and May 2016 with 112 participants of people diagnosed with schizophrenia.
Participants aged 18 years or older with DSM-V schizophrenia or schizoaffective disorder from outpatient mental health clinics in Jordan, were randomly assigned participants either to receive 6 weeks of a booklet form of intervention with face to face discussion, and treatment as usual [TAU] (intervention, n = 56), or TAU (control, n = 56).
Participants were assessed at baseline, immediately post-intervention (post-treatment1) and at three months follow-up.
The primary outcome measure was change in helplessness score .
Secondary outcomes for PDwS were psychiatric symptoms, recovery rate and quality of life.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
102
Fase
- Fase 2
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
16 år til 65 år (Barn, Voksen, Ældre voksen)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Adult aged 16 years or more
- Able to read and write in an Arabic
- Able to consent
- Diagnosed with schizophrenia
- Volunteers
Exclusion Criteria:
- Learning disability
- Not able to read or write
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Intervention
Intervention group received 6 weeks of empowerment program
|
6 weeks of empowerment program and supported face to face discussion
|
|
Ingen indgriben: Treatment as usual
Medications
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Modified Learned Helplessness
Tidsramme: Up to 6 months
|
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
|
Up to 6 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Psychiatric symptoms
Tidsramme: Up to 6 months
|
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
|
Up to 6 months
|
|
recovery assessment scale
Tidsramme: Up to 6 months
|
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
|
Up to 6 months
|
|
Empowerment level
Tidsramme: Up to 6 months
|
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
|
Up to 6 months
|
|
Quality of life
Tidsramme: Up to 6 months
|
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
|
Up to 6 months
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. november 2015
Primær færdiggørelse (Faktiske)
1. maj 2016
Studieafslutning (Faktiske)
1. maj 2016
Datoer for studieregistrering
Først indsendt
14. november 2016
Først indsendt, der opfyldte QC-kriterier
17. november 2016
Først opslået (Skøn)
18. november 2016
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
18. november 2016
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
17. november 2016
Sidst verificeret
1. november 2016
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- FakeehCMS
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .